EVA LOCK: Open Payments
NPI 1275904625 · PADUCAH, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,326 in 93 payments from 14 companies in 2025. Trend: 2023 $1,296 · 2024 $1,430 · 2025 $1,326
Food & beverage: $1,326
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $351 |
| Otsuka America Pharmaceutical, Inc. | 9 | $192 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $178 |
| Corium, LLC | 13 | $173 |
| Tris Pharma Inc | 4 | $75 |
| Amgen Inc. | 4 | $73 |
| Novo Nordisk Inc | 4 | $69 |
| Supernus Pharmaceuticals, Inc. | 3 | $54 |
| Collegium Pharmaceutical, Inc. | 3 | $51 |
| PFIZER INC. | 2 | $31 |
Products named: REXULTI, CAPLYTA, Azstarys, QULIPTA, UBRELVY, Dyanavel XR, VRAYLAR, Wegovy.
Industry payments across KY — which companies pay providers there.
